Supplement Firms Making Drug Claims Land On Fast Track To Notoriety At FDA
This article was originally published in The Tan Sheet
FDA is compiling an ongoing list of “online advisory letters” to identify supplement firms that fail to respond within 30 days to notices about noncompliant claims. The agency anticipates spurring an uptick in NDI notifications by publishing a draft guidance by the end of the year.
Register for our free email digests: